Together, these data demonstrate that this screening strategy in KIC Rgs16::GFP mice is a relatively rapid means for identifying novel or repurposed drugs, as well as new drug combinations, for treatment of Kras-dependent PDA. The gene discussed is KRAS; the disease is Patent ductus arteriosus.